Metamizole (sodium salt)

Metamizole (sodium salt) (CAS No.: 68-89-3) is an important non-opioid prodrug that primarily exerts its effects in biomedical research through the metabolites 4-methylaminoantipyrine (MAA) and 4-aminoantipyrine (AA). These metabolites exhibit significant analgesic and antipyretic properties and are commonly used to study anti-inflammatory and analgesic pathways. As an inhibitor of cyclooxygenase enzymes (COX-1 and COX-2), Metamizole reduces the synthesis of pro-inflammatory prostaglandins, providing a powerful tool for elucidating the pathophysiological mechanisms of inflammation and pain. In neuropharmacology research, its inhibitory effect on platelet aggregation in human platelet-rich plasma and its modulation of calcium levels in neuronal cell models further demonstrate its diverse application potential. In addition, this compound can inhibit cell proliferation, promote apoptosis, and possesses antioxidant activity. The in vitro activity of Metamizole is observed at low micromolar levels, which makes it significant in drug discovery and development. It is widely used in various cell models and animal studies to reveal the underlying mechanisms of nociception and inflammation, and the concentrations and doses used in experiments are usually determined according to the specific experimental design and research objectives.